Whole exome sequencing study of a Chinese concurrent cancer family.

Oncol Lett

Department of General Surgery, The Second People's Hospital, Three Gorges University, Yichang, Hubei 443002, P.R. China.

Published: September 2019

AI Article Synopsis

  • Cancer is a significant public health issue in China, with rising rates of incidence and mortality, particularly concerning concurrent cancers defined as having multiple primary malignancies in an individual.
  • A Chinese family with several concurrent cancer cases was studied using whole exome sequencing to identify genetic mutations that could explain their conditions.
  • The analysis highlighted the NADH:ubiquinone oxidoreductase core subunit S7 as a candidate gene for somatic mutations and identified 16 other genes with germline mutations, providing new insights into the molecular causes of concurrent cancers.

Article Abstract

Cancer is one of the leading causes of mortality in China, and poses a threat to public health due to its increasing incidence and mortality rates. Concurrent cancer is defined as one or more organs in the same individual having ≥2 primary malignancies occurring simultaneously or successively; however, concurrent cases are rare and poorly studied. The present study recruited a Chinese family presenting multiple cases of concurrent cancer and performed whole exome sequencing in one unaffected and two affected individuals to identify the causative mutations. DNA was extracted from peripheral blood and tumor tissue samples. Following an exome capture and quality test, the qualified library was sequenced as 100 bp paired-end reads on an Ion Torrent platform. Clean data were obtained by filtering out the low-quality reads. Subsequently, bioinformatics analyses were performed using the clean data. After mapping and annotating in 1000 Genomes Project database, the existing SNP database and the Cancer Gene Census (CGC) database, it was revealed that the NADH:ubiquinone oxidoreductase core subunit S7 gene was a candidate gene with somatic mutations, and a subset of 16 genes were candidate genes with germline mutations. The findings of the present study may improve the understanding of the molecular pathogenesis of concurrent cancer.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676670PMC
http://dx.doi.org/10.3892/ol.2019.10573DOI Listing

Publication Analysis

Top Keywords

concurrent cancer
16
exome sequencing
8
clean data
8
cancer
6
concurrent
5
sequencing study
4
study chinese
4
chinese concurrent
4
cancer family
4
family cancer
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!